These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3728366)

  • 1. Calcium supplements in the prevention of steroid-induced osteoporosis.
    Reid IR; Ibbertson HK
    Am J Clin Nutr; 1986 Aug; 44(2):287-90. PubMed ID: 3728366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women.
    Horowitz M; Need AG; Philcox JC; Nordin BE
    Horm Metab Res; 1985 Jun; 17(6):311-2. PubMed ID: 4018720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical effects of calcium supplementation in postmenopausal osteoporosis.
    Horowitz M; Need AG; Morris HA; Wishart J; Nordin BE
    Eur J Clin Nutr; 1988 Sep; 42(9):775-8. PubMed ID: 3181110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of glucocorticoid-induced osteoporosis.
    Reid IR; Schooler BA; Stewart AW
    J Bone Miner Res; 1990 Jun; 5(6):619-23. PubMed ID: 2200239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor 1 and bone turnover in glucocorticoid-treated and control subjects.
    Reid IR; Gluckman PD; Ibbertson HK
    Clin Endocrinol (Oxf); 1989 Apr; 30(4):347-53. PubMed ID: 2598471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women.
    Horowitz M; Need AG; Philcox JC; Nordin BE
    Am J Clin Nutr; 1984 Jun; 39(6):857-9. PubMed ID: 6720619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age.
    Elders PJ; Netelenbos JC; Lips P; van Ginkel FC; Khoe E; Leeuwenkamp OR; Hackeng WH; van der Stelt PF
    J Clin Endocrinol Metab; 1991 Sep; 73(3):533-40. PubMed ID: 1874931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low-dose prednisone on bone metabolism.
    Ton FN; Gunawardene SC; Lee H; Neer RM
    J Bone Miner Res; 2005 Mar; 20(3):464-70. PubMed ID: 15746991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disorders of calcium and bone metabolism in glucocorticoid treatment].
    Kruse K; Büsse M; Kracht U; Kruse U; Wohlfart K
    Monatsschr Kinderheilkd; 1988 May; 136(5):237-42. PubMed ID: 2841591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate.
    Adami S; Fossaluzza V; Rossini M; Bertoldo F; Gatti D; Zamberlan N; Lo Cascio V
    Bone Miner; 1991 Oct; 15(1):73-81. PubMed ID: 1747568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate.
    Grecu EO; Weinshelbaum A; Simmons R
    Calcif Tissue Int; 1990 May; 46(5):294-9. PubMed ID: 2140069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1alpha-hydroxycholecalciferol in senile osteoporosis and in bone loss following prednisone treatment.
    Sorensen OH; Lund B; Friis TH; Hjorth L; Reimann I; Kjaer I; Andersen RB
    Isr J Med Sci; 1977 Mar; 13(3):253-8. PubMed ID: 852974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NaCl on calcium balance, parathyroid function and hydroxyproline excretion in prednisolone-treated rats consuming low calcium diet.
    Goulding A; McIntosh J
    J Nutr; 1986 Jun; 116(6):1037-44. PubMed ID: 3014091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
    Nielsen HK; Thomsen K; Eriksen EF; Charles P; Storm T; Mosekilde L
    Bone Miner; 1988 Apr; 4(1):105-13. PubMed ID: 3263890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phosphorus supplementation on serum parathyroid hormone and bone morphology in osteoporosis.
    Goldsmith RS; Jowsey J; Dubé WJ; Riggs BL; Arnaud CD; Kelly PJ
    J Clin Endocrinol Metab; 1976 Sep; 43(3):523-32. PubMed ID: 956340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of estrogen (Premarin) replacement therapy on serum level of total estrogen and urinary excretion of calcium and hydroxyproline in postmenopausal Chinese women.
    Ouyang PC; Chow SN; Huang SC; Hsieh CY
    Proc Natl Sci Counc Repub China B; 1986 Jul; 10(3):162-6. PubMed ID: 3022320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in calcium and bone metabolism during treatment with low dose prednisone in young, healthy, male volunteers.
    Lems WF; Jacobs JW; Van Rijn HJ; Bijlsma JW
    Clin Rheumatol; 1995 Jul; 14(4):420-4. PubMed ID: 7586978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis.
    McDonough RP; Doucette WR; Kumbera P; Klepser DG
    Value Health; 2005; 8(1):24-31. PubMed ID: 15841891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.